TL;DR: Ditto Biosciences is a Y Combinator Winter 2026 startup Evolutionary intelligence for autoimmune disease, currently active with a team of 3.
Evolutionary intelligence for autoimmune disease
Last verified:
Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology. Viruses, ticks, and worms have experimented over millions of years to create proteins that control the human immune system. We use AI to identify these proteins and engineer them into next-generation autoimmune therapies. Our team is three PhD scientists from UCSF, UCSD, and UC Berkeley who have worked together for 3+ years in biotech. We have deep expertise in parasite biology, computational biology, and software for AI-based protein structure prediction
Built by LemStudio
Yes. Ditto Biosciences was funded by Y Combinator in the Winter 2026 batch. Evolutionary intelligence for autoimmune disease
Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology. Viruses, ticks, and worms have experimented over millions of years to create proteins that control the human immune system. We use AI to identify these proteins and engineer them into next-generation autoimmune therapies. Our team is thr…
Ditto Biosciences was part of Y Combinator's Winter 2026 batch.
Ditto Biosciences has a team of 3 people according to Y Combinator's directory.
Ditto Biosciences is currently listed as Active with a team of 3 in Y Combinator's directory.
Loading interactive view…